Alto Neuroscience (ANRO) Stock Forecast & Price Target

ANRO price $24.00 +0.67 +2.87%

Ticker
ANRO
Price
$24.00
Change
+0.67 +2.87%
Market cap ?
$941.81M
P/E ?
-8.95
Dividend yield ?
0.00%
Beta ?
1.16
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
72
Value
42
Quality
76
Growth
99

Stocklytics score rationale: value 42, quality 76, growth 99.

Financials

20212022202320242025
2100000000

Alto Neuroscience, Inc. operates as a biopharmaceutical entity in the clinical stage, specializing in the creation of novel psychiatric medications. Its development pipeline includes ALTO-100, an investigational therapy targeting individuals affected by major depressive disorder (MDD) and post-traumatic stress disorder. Also in its portfolio is ALTO-300, a small molecule designed to function as both a melatonergic…

Fair value

ANRO fair value Not meaningful. Price $24.00.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ANRO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.67——
2026-08-12-0.65-0.73——
2026-05-13-0.80-0.56——
2026-03-16-0.45-0.56——
2025-11-12-0.52-0.66——
2025-08-13-0.65-0.57——
2025-05-14-0.53-0.59——
2025-03-20-0.56-0.65——
2024-11-12-0.62-0.67——
2024-08-13-0.60-0.71——
2024-05-14-0.76-0.46——
2024-03-21-7.77-1.67——
2024-02-05-0.34———
2023-06-29-0.32———
2023-03-31-0.27———
2022-12-31-0.30———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-02Smith Nicholas ConradBuy55.00K$2.32127.60K
2026-10-02Smith Nicholas ConradSell55.00K$2.32127.60K
2026-09-30Smith Nicholas ConradSell24.06K$2.3556.53K
2026-09-30Smith Nicholas ConradBuy24.06K$2.3556.53K
2026-09-30Smith Nicholas ConradSell23.17K$25.78597.29K
2026-09-30Smith Nicholas ConradSell886$26.8723.81K
2026-09-29Smith Nicholas ConradSell56.45K$2.35132.67K
2026-09-29Smith Nicholas ConradBuy54.38K$2.35127.78K
2026-09-29Smith Nicholas ConradBuy56.45K$2.35132.67K
2026-09-29Smith Nicholas ConradSell54.38K$2.35127.78K
2026-09-29Smith Nicholas ConradSell110.83K$26.582.95M
2026-05-27Miller Andrew CraigBuy26.00K$20.44531.44K
2026-05-27Miller Andrew CraigOther0——
2026-05-14Etkin AmitSell400.00K——
2026-05-12Sanchez RamiroBuy10.96K$24.63269.90K
2026-05-12Cox Christopher NixonBuy10.96K$24.63269.90K
2026-05-12Manji HusseiniBuy10.96K$24.63269.90K
2026-05-12Dreyfus AndrewBuy10.96K$24.63269.90K
2026-05-12York GwillBuy10.96K$24.63269.90K
2026-03-01Etkin AmitSell6.23K$19.69122.61K
2026-03-01Smith Nicholas ConradSell2.81K$19.6955.25K
2026-02-11Etkin AmitBuy306.00K$16.715.11M
2026-02-11Savitz AdamBuy124.00K$16.712.07M
2026-02-11Smith Nicholas ConradBuy200.00K$16.713.34M
2026-02-11Hanley Jr. Michael ConickBuy131.00K$16.712.19M
2026-01-02York GwillBuy5.24K$16.5986.98K
2026-01-02Cox Christopher NixonBuy7.19K$16.59119.27K
2026-01-02Manji HusseiniBuy4.23K$16.5970.14K
2026-01-02Sanchez RamiroBuy3.81K$16.5963.14K
2025-08-12Sanchez RamiroBuy30.57K$3.1897.23K
2025-08-12Sanchez RamiroBuy3.93K$3.1812.49K
2025-08-12Sanchez RamiroOther0——
2025-07-03Hanley Jr. Michael ConickBuy188.00K$2.35441.80K
2025-07-03Hanley Jr. Michael ConickBuy125.00K$2.35293.75K
2025-07-03Hanley Jr. Michael ConickBuy8.00K$2.3518.80K
2025-07-03Hanley Jr. Michael ConickSell188.00K$12.402.33M
2025-07-03Hanley Jr. Michael ConickSell125.00K$4.20525.00K
2025-07-03Hanley Jr. Michael ConickSell8.00K$14.88119.04K
2025-07-03Savitz AdamBuy123.64K$2.35290.57K
2025-07-03Savitz AdamBuy76.00K$2.35178.60K
2025-07-03Savitz AdamBuy73.00K$2.35171.55K
2025-07-03Savitz AdamBuy33.01K$2.3577.57K
2025-07-03Savitz AdamBuy22.48K$2.3552.83K
2025-07-03Savitz AdamSell123.64K$5.30655.32K
2025-07-03Savitz AdamSell33.01K$6.23205.64K
2025-07-03Savitz AdamSell73.00K$14.881.09M
2025-07-03Savitz AdamSell76.00K$4.20319.20K
2025-07-03Etkin AmitBuy247.29K$2.35581.13K
2025-07-03Etkin AmitBuy223.00K$2.35524.05K
2025-07-03Etkin AmitBuy215.00K$2.35505.25K
2025-07-03Etkin AmitBuy34.62K$2.3581.36K
2025-07-03Etkin AmitSell223.00K$14.883.32M
2025-07-03Etkin AmitSell34.62K$6.23215.68K
2025-07-03Etkin AmitSell215.00K$4.20903.00K
2025-07-03Etkin AmitSell247.29K$5.301.31M
2025-07-03Smith Nicholas ConradBuy202.33K$2.35475.47K
2025-07-03Smith Nicholas ConradBuy135.00K$2.35317.25K
2025-07-03Smith Nicholas ConradBuy90.00K$2.35211.50K
2025-07-03Smith Nicholas ConradBuy44.96K$2.35105.66K
2025-07-03Smith Nicholas ConradBuy33.83K$2.3579.51K
2025-07-03Smith Nicholas ConradSell202.33K$5.301.07M
2025-07-03Smith Nicholas ConradSell33.83K$6.23210.78K
2025-07-03Smith Nicholas ConradSell135.00K$4.20567.00K
2025-07-03Smith Nicholas ConradSell90.00K$14.881.34M
2025-05-13Manji HusseiniBuy15.29K$2.3736.23K
2025-05-13Cox Christopher NixonBuy15.29K$2.3736.23K
2025-05-13Dreyfus AndrewBuy15.29K$2.3736.23K
2025-05-13York GwillBuy15.29K$2.3736.23K
2025-02-05Hanley Jr. Michael ConickBuy125.00K$4.20525.00K
2025-02-05Smith Nicholas ConradBuy135.00K$4.20567.00K
2025-02-05Savitz AdamBuy76.00K$4.20319.20K
2025-02-05Etkin AmitBuy215.00K$4.20903.00K
2025-01-02York GwillBuy19.56K$4.3885.66K
2025-01-02Manji HusseiniBuy14.20K$4.3862.17K
2025-01-02Cox Christopher NixonBuy25.24K$4.38110.53K
2024-07-10Savitz AdamBuy2.93K$13.2238.75K
2024-07-09Savitz AdamBuy1.39K$13.1518.25K
2024-07-09Savitz AdamBuy10.68K$12.53133.83K
2024-05-20Hanley Jr. Michael ConickBuy188.00K$12.402.33M
2024-05-20Hanley Jr. Michael ConickOther8.00K$14.88119.04K
2024-03-28Smith Nicholas ConradBuy4.55K$16.5675.35K
2024-03-28Smith Nicholas ConradBuy1.60K$15.8025.28K
2024-03-08Radhakrishnan MahaBuy30.57K$13.76420.70K
2024-03-08Radhakrishnan MahaBuy1.59K$13.7621.88K
2024-03-08Radhakrishnan MahaOther0——
2024-03-01Savitz AdamBuy73.00K$14.881.09M
2024-03-01Etkin AmitBuy34.71K——
2024-03-01Etkin AmitBuy223.00K$14.883.32M
2024-03-01Smith Nicholas ConradBuy90.00K$14.881.34M
2024-03-01Smith Nicholas ConradBuy19.15K——
2024-02-06Apeiron Investment Group Ltd.Buy674.66K——
2024-02-06Apeiron Investment Group Ltd.Buy251.88K——
2024-02-06Apeiron Investment Group Ltd.Sell444.56K——
2024-02-06Apeiron Investment Group Ltd.Sell1.06M——
2024-02-06Apeiron Investment Group Ltd.Sell416.67K——
2024-02-06Alpha Wave Global, LPBuy600.00K$16.009.60M
2024-02-06Alpha Wave Global, LPBuy1.14M——
2024-02-06Alpha Wave Global, LPBuy1.96M——
2024-02-06Alpha Wave Global, LPSell1.96M——
2024-02-06Alpha Wave Global, LPSell1.14M——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 120, holders +6 vs prior quarter. Ownership 69.02%.

HolderSharesChangeChange %Value
ALPHA WAVE GLOBAL, LP3.71M00.00%97.85M
COMMODORE CAPITAL LP2.72M00.00%71.87M
BLACKROCK, INC.2.12M1.45M+218.38%55.97M
PERCEPTIVE ADVISORS LLC1.61M-400.00K-19.90%42.49M
ADAGE CAPITAL PARTNERS GP, L.L.C.1.60M1.22M+315.58%42.22M
VANGUARD CAPITAL MANAGEMENT LLC1.39M182.45K+15.12%36.67M
SPRUCE STREET CAPITAL LP1.35M27.84K+2.10%35.71M
VIVO CAPITAL, LLC1.21M173.31K+16.74%31.90M
FRANKLIN TEMPLETON INC1.01M-88.57K-8.04%26.74M
ARMISTICE CAPITAL, LLC864.00K-48.00K-5.26%22.80M
AFFINITY ASSET ADVISORS, LLC850.00K350.00K+70.00%22.43M
VESTAL POINT CAPITAL, LP785.00K-1.28M-61.97%20.72M
STATE STREET CORP685.95K486.44K+243.83%18.10M
GEODE CAPITAL MANAGEMENT, LLC678.20K385.30K+131.55%17.90M
72 INVESTMENT HOLDINGS, LLC667.78K00.00%17.62M
NORTHERN TRUST CORP632.70K159.30K+33.65%16.70M
MILLENNIUM MANAGEMENT LLC558.32K-263.66K-32.08%14.73M
POINT72 ASSET MANAGEMENT, L.P.502.95K-137-0.03%13.27M
VENROCK ADVISER, LLC500.00K00.00%13.20M
INTEGRAL HEALTH ASSET MANAGEMENT, LLC500.00K00.00%13.20M
DRIEHAUS CAPITAL MANAGEMENT LLC487.58K850+0.17%12.87M
PARKMAN HEALTHCARE PARTNERS LLC429.04K429.04KNew11.32M
IKARIAN CAPITAL, LLC407.34K-107.66K-20.91%10.75M
PRICE T ROWE ASSOCIATES INC /MD/358.28K-12.93K-3.48%9.46M
ORBIMED ADVISORS LLC257.85K90.35K+53.94%6.80M

Forecast

Consensus Buy from 9 analysts. Average price target $39.25, +63.5% versus the current price. Low $24.00. High $60.00.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Analysts have an average 12-month price target of $39.25 for Alto Neuroscience (ANRO), 65.8% above the current price of $23.68. Of 9 analysts covering the stock, 8 rate it Buy or Strong Buy, 1 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.

Forecasts are third-party estimates and often wrong. They are not investment advice.

ANRO price target

12-month price target
Low$24.00
Average$39.25
High$60.00

The average is 65.8% above the current price of $23.68.

Is Alto Neuroscience a buy or sell?

Of 9 analysts, 8 rate Alto Neuroscience Buy or Strong Buy, 1 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.

Alto Neuroscience earnings and revenue forecast

Analyst averages on file: 2026, EPS -2.79, revenue $0. 2027, EPS -3.01, revenue $0.

ANRO score and fair value

The Stocklytics Score for ANRO is 72 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.

ANRO forecast FAQs

What is the ANRO price target?

$39.25 average, with a published range of $24.00 to $60.00.

Is Alto Neuroscience a buy or sell?

The consensus is Buy from 9 analysts. This is not a recommendation.

What is the Alto Neuroscience stock forecast for 2026?

Analysts' average EPS estimate for 2026 on file is -2.79. The average revenue estimate is $0.

What will ANRO be worth in 2030?

No reliable forecast exists that far out.

When is Alto Neuroscience's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Related: Alto Neuroscience · Financials · Dividends · Compare · AI stocks

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

Alto Neuroscience (ANRO) Stock Forecast & Price Target

ANRO$24.00+0.67 +2.87%

$941.81M

Market Cap

-8.95

P/E

—

Forward P/E

72

Score

Price History